ask="19.25"
ask_size="200"
average_daily_volume="186375"
bid="12.15"
bid_size="100"
book_value="6.18"
change="+0.60"
change_from_200_day_moving_average="1.53"
change_from_50_day_moving_average="-0.92"
change_from_52_week_high="-4.95"
change_From_52_week_low="7.00"
change_in_percent="+3.20%"
close="19.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.18"
ebitda="-77.71M"
eps_estimate_current_year="-3.60"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-3.31"
ex_dividend_date="N/A"
float_shares="19254000"
high="19.40"
high_52_weeks="24.30"
last_trade_date="3/10/2017"
last_trade_price="19.35"
last_trade_size="12264"
last_trade_time="4:00pm"
low="18.90"
low_52_weeks="12.35"
market_capitalization="567.32M"
moving_average_200_day="17.82"
moving_average_50_day="20.27"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="39.67"
open="18.90"
pe_ratio="N/A"
peg_ratio="-0.45"
percent_change_from_200_day_moving_average="+8.58%"
percent_change_from_50_day_moving_average="-4.56%"
percent_change_from_52_week_high="-20.37%"
percent_change_from_52_week_low="+56.68%"
previous_close="18.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.03"
price_per_sales="1832.44"
revenue="300000.00"
shares_outstanding="29319000"
short_ratio="32.21"
stock_exchange="NGM"
symbol="RVNC"
volume="225276"
weeks_range_52="12.35 - 24.30"
